UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency basliginda one cikan gelisme: The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.